Kibow® Biotech Wins 2026 WebAward for Best Science Website

Recognition Highlights Kibow's Continued Commitment to Advancing Kidney Health Education, Innovation, and Global Access

EXTON, Pa., Sept. 16, 2026 /PRNewswire/ -- Kibow Biotech, a leading innovator of science-based solutions for kidney health and the 2026 American Association of Naturopathic Physicians Corporation of the Year, today announced that its newly redesigned website, KibowBiotech.com, has been named Best Science Website in the 2026 WebAward Competition.

Presented by the Web Marketing Association, the annual WebAward Competition recognizes excellence in website development across seven criteria, including design, innovation, content, and ease of use. KibowBiotech.com earned the 2026 honor for Best Science Website.

The award comes as Kibow continues to expand both its reach and its commitment to kidney health. Founded in 1997, Kibow has spent nearly 30 years pioneering research into the gut-kidney axis and translating that science into practical solutions for people focused on maintaining kidney health. Its mission is to develop safe, effective, and accessible microbiome-based solutions that improve kidney health and the daily lives of patients.

"For nearly 30 years, our focus has been on advancing the science of kidney health while helping more people understand the important role the gut can play in supporting kidney function," said Mike Kane, President of Kibow Biotech. "Our website gives us another powerful way to share that science, increase awareness, and provide people with credible kidney health information wherever they are. We're honored by this recognition and excited to continue expanding the ways we can educate and support the kidney community."

That commitment is increasingly global. Kibow's flagship product, Renadyl^®, a clinically studied probiotic dietary supplement developed to support kidney health through the gut-kidney axis, is now available worldwide, including upcoming expansion into Canada. The milestone reflects Kibow's continued efforts to broaden access to its kidney health solutions internationally.

Kibow is also preparing to expand its kidney-health mission beyond people with the upcoming launch of Renaphil™, a kidney probiotic scientifically formulated for cats and dogs. Developed from Kibow's decades of experience studying the gut-kidney connection, Renaphil will bring the company's microbiome science to companion animals and the families who care for them.

The award-winning KibowBiotech.com was created in collaboration with PRISM Marketing, an award-winning, woman-owned marketing agency with more than 30 years of experience helping organizations translate complex business and healthcare challenges into research-driven marketing strategies and communications.

"We're incredibly proud to see Kibow Biotech receive this recognition," said Michelle Adams, President and Founder of PRISM Marketing. "Kibow has an important story to tell, built on decades of science, innovation and a genuine dedication to improving the lives of people affected by kidney health challenges. Our goal was to create a website that made that story and the science behind it more accessible and engaging. We're proud to work alongside the Kibow team and help extend the reach of that mission."

The new website brings together Kibow's kidney health research, educational resources, product portfolio and nearly three decades of work advancing the understanding of the gut-kidney axis. Visitors can explore clinical trials, scientific posters and peer-reviewed publications, learn more about chronic kidney disease and the role of the gut microbiome, and access information about Kibow's growing portfolio of kidney health solutions.

About Kibow Biotech, LLC.

Kibow Biotech develops science-based solutions to support kidney health by targeting the gut-kidney axis. Founded in 1997, Kibow has been an early pioneer in researching the interaction between the intestinal microbiome and renal function and translating that science into practical solutions for kidney health. Its portfolio includes Renadyl^®, its clinically studied probiotic dietary supplement for kidney health, Renadyl^® Advanced Multivitamin, Kibow Fortis®, and other kidney-specific products designed to support patients at different stages of care. Kibow's mission is to apply rigorous science to develop safe, effective and accessible microbiome-based solutions that improve kidney health and the daily lives of patients.

Contact Information:
Michelle Adams
President
PRISM Marketing
614-989-6373
[email protected]

SOURCE Kibow Biotech